Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome
- PMID: 31009912
- DOI: 10.1016/j.ejmech.2019.04.030
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome
Abstract
A multitarget pharmacologic approach could be advantageous for the therapy of metabolic multiple diseases, such as the metabolic syndrome, which is characterized by metabolic abnormalities associated with diabetes, obesity, hypertension, and increased cardiovascular risk. PPAR receptors play a critical role in metabolic disorders, affecting glucose and lipid metabolism. Drugs simultaneously targeting PPAR and other validated metabolic targets, represent a promising multitarget approach to combine antihyperglycemic, antihyperlipidemic, and antihypertensive effects. This review offers a survey of recently developed multitarget PPARγ agonists as antidiabetic and antihypertensive drugs.
Keywords: AT1 receptor; FFAR1; GK; Metabolic syndrome; Multitarget drugs; PPAR; PTP1B; SUR; sEH.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Design, synthesis, and activity evaluation of GK/PPARγ dual-target-directed ligands as hypoglycemic agents.ChemMedChem. 2014 May;9(5):922-7. doi: 10.1002/cmdc.201400009. Epub 2014 Apr 15. ChemMedChem. 2014. PMID: 24737574
-
Selective PPARγ modulators for Type 2 diabetes treatment: how far have we come and what does the future hold?Future Med Chem. 2018 Apr 1;10(7):703-705. doi: 10.4155/fmc-2018-0021. Epub 2018 Apr 19. Future Med Chem. 2018. PMID: 29671628 No abstract available.
-
Can PPARgamma agonists have a role in the management of obesity-related hypertension?Vascul Pharmacol. 2006 Jul;45(1):46-53. doi: 10.1016/j.vph.2005.11.010. Epub 2006 May 19. Vascul Pharmacol. 2006. PMID: 16713364 Review.
-
Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists.Eur J Med Chem. 2016 Feb 15;109:157-72. doi: 10.1016/j.ejmech.2015.12.049. Epub 2015 Dec 31. Eur J Med Chem. 2016. PMID: 26774923
-
Thiazolidinediones as antidiabetic agents: A critical review.Bioorg Chem. 2018 Apr;77:548-567. doi: 10.1016/j.bioorg.2018.02.009. Epub 2018 Feb 12. Bioorg Chem. 2018. PMID: 29475164 Review.
Cited by
-
Phenylsulfonimide PPARα Antagonists Enhance Nrf2 Activation and Promote Oxidative Stress-Induced Apoptosis/Pyroptosis in MCF7 Breast Cancer Cells.Int J Mol Sci. 2023 Jan 10;24(2):1316. doi: 10.3390/ijms24021316. Int J Mol Sci. 2023. PMID: 36674831 Free PMC article.
-
Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.Physiol Rev. 2021 Oct 1;101(4):1745-1807. doi: 10.1152/physrev.00030.2020. Epub 2021 May 5. Physiol Rev. 2021. PMID: 33949876 Free PMC article. Review.
-
In Combo Studies for the Optimization of 5-Aminoanthranilic Acid Derivatives as Potential Multitarget Drugs for the Management of Metabolic Syndrome.Pharmaceuticals (Basel). 2022 Nov 25;15(12):1461. doi: 10.3390/ph15121461. Pharmaceuticals (Basel). 2022. PMID: 36558912 Free PMC article.
-
A Critical Review and Meta-Analysis of Impacts of Per- and Polyfluorinated Substances on the Brain and Behavior.Front Toxicol. 2022 Apr 11;4:881584. doi: 10.3389/ftox.2022.881584. eCollection 2022. Front Toxicol. 2022. PMID: 35480070 Free PMC article. Review.
-
Combating Obesity With Thermogenic Fat: Current Challenges and Advancements.Front Endocrinol (Lausanne). 2020 Apr 15;11:185. doi: 10.3389/fendo.2020.00185. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32351446 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
Medical
Research Materials
Miscellaneous
